SCHEMBL30567114

SCHEMBL30567114

COc1cccc(Oc2ccccc2NC(=O)[C@@H](N)CCC(=O)OC(C)(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1B P49286 3/20 0.55
▸ SLC1A5 Q15758 1/20 0.45
▸ L3MBTL1 Q9Y468 4/20 0.44
▸ LMNA P02545 2/20 0.44
▸ PYGM P11217 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ POLB P06746 2/20 0.39
▸ LPAR1 Q92633 1/20 0.39
▸ ADRA2C P18825 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ MAPK10 P53779 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25388414 0.87 MTNR1B (0.60) MTNR1BSLC1A5L3MBTL1LMNAPYGM
SCHEMBL25388420 0.87 MTNR1B (0.60) MTNR1BSLC1A5L3MBTL1LMNAPYGM
SCHEMBL31256614 0.82 MTNR1B (0.69) MTNR1BL3MBTL1LMNAPYGMALDH1A1
SCHEMBL7401760 0.81 MITF (0.47) ALDH1A1POLB
SCHEMBL30567109 0.80 MTNR1B (0.48) MTNR1BLMNAPYGMALDH1A1POLB
SCHEMBL30567123 0.78 MTNR1B (0.54) MTNR1BL3MBTL1LMNAPYGMALDH1A1
SCHEMBL30567232 0.78 MTNR1B (0.44) MTNR1BTP53
SCHEMBL8145865 0.76 MTNR1B (0.65) MTNR1BL3MBTL1LMNAPYGMALDH1A1
SCHEMBL26270707 0.74 MTNR1B (0.64) MTNR1BL3MBTL1LMNAPYGMALDH1A1
SCHEMBL25386995 0.73 MTNR1B (0.75) MTNR1BL3MBTL1LMNAPYGMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250171404-A1 PCNA INHIBITORS AND USES THEREOF UNITED STATES GOVERNMENT 2025-05-29 — — US disclosed
EP-4490142-A2 PCNA INHIBITORS AND USES THEREOF City of Hope (US) 2025-01-15 — — EP disclosed
CN-119013247-A PCNA inhibitor and use thereof 希望之城 2024-11-22 — — CN disclosed
WO-2023172880-A2 PCNA INHIBITORS AND USES THEREOF CITY OF HOPE (US) 2023-09-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171404-A1 PCNA INHIBITORS AND USES THEREOF PCNA, MKI67, PCLAF MTNR1B 4532/4885SLC1A5 3480/4885L3MBTL1 1817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback